Ambient Air Pollution (PM2.5)

Exposure Definition

PM2.5 (particulate matter with aerodynamic diameter ≤2.5 micrometers) refers to fine inhalable particles that can penetrate deep into the lungs and enter the bloodstream. Sources include combustion (vehicles, power plants, wildfires), industrial processes, and secondary formation from gaseous precursors (e.g., SO2, NOx). PM2.5 composition varies by region but typically includes sulfates, nitrates, ammonium, organic carbon, elemental carbon, and trace metals. The small size enables alveolar deposition and systemic distribution, contributing to respiratory, cardiovascular, and immune effects.

Proxies

Name	Unit	Measurement	Data source
PM2.5	μg/m³	Gravimetric analysis (Federal Reference Method); continuous monitors use beta-attenuation or light scattering	EPA Air Quality System (AQS)

Data Sources

Data source: EPA AQS monitors

Geographic scope: United States

Summary stats: {"mean_annual_ug_m3":9,"urban_typical_ug_m3":12,"wildfire_spike_ug_m3":50}

Biological Systems Affected

respiratory

PM2.5 induces oxidative stress and NF-κB activation in airway epithelium; upregulates IL-33, TSLP, IL-6, IL-8; exacerbates asthma and COPD; impairs mucociliary clearance

cardiovascular

Systemic inflammation, endothelial dysfunction, increased blood viscosity, autonomic imbalance; contributes to myocardial infarction, stroke, and heart failure

immune

Modifies dendritic cell function and Th1/Th2 balance; amplifies allergic sensitization and IgE production in susceptible individuals; dampens antiviral defenses

Sensitive Developmental Windows

prenatal (in utero) (gestational weeks 0-40)

In utero exposure affects lung development (alveolarization, airway branching); epigenetic modifications may prime inflammatory pathways; maternal inflammation crosses placenta.

Developmental context: Lung branching morphogenesis (weeks 5-17) and early alveolarization are vulnerable to PM2.5-induced oxidative stress. Epigenetic modifications (DNA methylation at IL33, TSLP promoters) may be programmed during this period. Maternal systemic inflammation crosses the placenta and can alter fetal immune priming.

lung branching morphogenesisalveolarizationepigenetic programmingimmune priming

early childhood (0-5) (0-5 years)

Immune system maturation; higher ventilation rates and mouth-breathing increase dose; first allergic sensitization often occurs; airway remodeling initiated.

Developmental context: Immune system maturation and first allergic sensitization occur during this window. Higher ventilation rates per body weight increase effective PM2.5 dose. Alveolar septation continues through age 2-3. First IgE sensitization to aeroallergens often occurs during this window, establishing atopic trajectories.

immune maturationalveolar septationallergic sensitizationIgE class switching

adolescence (10-24) (10-24 years)

Lung growth continues into early 20s; behavioral changes (outdoor activity, commuting) alter exposure; occupational exposures may begin; smoking initiation amplifies effects.

Developmental context: Lung growth continues into early 20s (total lung capacity not reached until age 20-22). Behavioral changes (commuting, outdoor sports, occupational exposure) alter exposure patterns. Smoking initiation in this period creates additive oxidative burden. Hormonal changes may modulate immune responses and airway reactivity.

alveolar maturationbehavioral exposure changeshormonal immune modulationsmoking initiation

GxE Highlights

Gene	Disease	Direction	Strength	Confidence	Evidence
il33	asthma	amplify	0.78	high	literature
gstp1	asthma	amplify	0.72	medium	literature
tnf	asthma	amplify	0.65	medium	literature
ormdl3	asthma	amplify	0.70	low	GWAS
gsdmb	asthma	amplify	0.60	low	GWAS

il33 × asthma

IL33 promoter variants increase epithelial alarmin release under PM2.5-induced NF-kB activation; carriers show amplified Th2 airway inflammation in exposed populations.

gstp1 × asthma

GSTP1 Ile105Val variant reduces glutathione conjugation of PM2.5-derived ROS; carriers show stronger air pollution-asthma associations in childhood cohorts.

tnf × asthma

TNF-308 promoter variant increases TNF-alpha production under PM2.5 exposure; amplifies NF-kB-driven airway inflammation in genetically susceptible individuals.

ormdl3 × asthma

ORMDL3 17q21 variants regulate sphingolipid metabolism and ER stress; PM2.5 exposure may amplify ER stress in carriers, though direct GxE evidence is emerging.

gsdmb × asthma

GSDMB 17q21 variants associated with pyroptosis and epithelial barrier disruption; PM2.5-induced epithelial damage may be amplified in risk-allele carriers.

Tissue-Specific Notes

bronchial epithelium— inflammatory upregulation

pulmonary endothelium— activation

alveolar macrophages— cytokine secretion

References

1.Li R, et al. (2017). Exposure to PM2.5 induces aberrant activation of NF-κB in human airway epithelial cells by downregulating miR-331 expression. Environmental Toxicology and Pharmacology. doi:10.1016/j.etap.2017.02.011
2.Brandenburg AH, et al. (2014). Ambient particulate matter induces an exacerbation of airway inflammation in experimental asthma: role of interleukin-33. Clinical & Experimental Immunology. doi:10.1111/cei.12348
3.Islam T, et al. (2014). GSTP1 and TNF Gene Variants and Associations between Air Pollution and Incident Childhood Asthma. Environmental Health Perspectives. doi:10.1289/ehp.1307459
4.McConnell R, et al. (2015). Traffic-related air pollution exposure and incident asthma in a high-risk birth cohort. Occupational and Environmental Medicine. doi:10.1136/oemed-2014-102726
5.U.S. EPA (2024). EPA Criteria Air Pollutants. [link]
6.Moffatt MF, et al. (2007). Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature. doi:10.1038/nature06014